ReviewJournal of thrombosis and thrombolysis2026
Pathological, diagnostic, and therapeutic implications of non-coding RNAs in deep vein thrombosis: A comprehensive review.
Review in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep vein thrombosis (DVT) is a prevalent thrombotic condition affecting a wide range of patients, including post-partum women, immobilized individuals, and those who have undergone surgery, suffered heavy trauma, or had malignancies. Given the high incidence of the disease, identifying molecular and genetic tools that can predict, indicate prognosis, and serve as therapeutic targets would be a significant advancement in clinical practice for a broad spectrum of patients. However, traditional treatments often face challenges, leading to post-thrombotic syndrome (PTS) development in complex cases. Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have demonstrated essential regulatory roles in cellular pathways and have been found to be dysregulated in DVT patients and animal models. This knowledge provides new insights into the pathophysiology of DVT and paves the way for utilizing ncRNAs as diagnostic, predictive, and prognostic indicators, as well as therapeutic targets. Recent advancements have led to significant recanalization of thrombosed veins in animal models. In this review, we delve into the current literature on ncRNAs in DVT to highlight their potential for understanding disease mechanisms and improving patient outcomes.
Indexed as
Identifiers
41222885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.